Dallas, TXNCT06343311Now EnrollingIRB Ready

Non-Hodgkin's Lymphoma Clinical Trial in Dallas, TX

Access cutting-edge non-hodgkin's lymphoma treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.

Sponsored by Estrella Biopharma, Inc.

Quick Self-Assessment

See if you qualify for this Dallas location

Preparing your pre-screening questions...

Expert Care in Dallas

Access non-hodgkin's lymphoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related non-hodgkin's lymphoma treatment provided free

Apply for This Dallas Location

Check if you qualify for this non-hodgkin's lymphoma clinical trial in Dallas, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Dallas

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Dallas site if eligible
  4. 4Begin participation

About This Non-Hodgkin's Lymphoma Study in Dallas

This is an open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety of an autologous T-cell therapy (EB103) and to determine the Recommended Phase II Dose (RP2D) in adult subjects (≥ 18 years of age) who have relapsed/refractory (R/R) B-cell NHL. The study will include a dose escalation phase followed by an expansion phase.

Sponsor: Estrella Biopharma, Inc.

Who Can Participate

Inclusion Criteria

Age 18 years or older at the time of informed consent
Histologically confirmed R/R B-cell non-Hodgkin's lymphoma (NHL)
Adequate organ function
Relapsed or refractory (R/R) disease defined as ONE OR MORE of the following:
R/R after ≥ 2 lines of systemic therapy
For the following NHL types: Burkitt lymphoma, Precursor B-cell lymphoblastic lymphoma, or Mantle cell lymphoma: R/R after ≥ 1 lines of systemic therapy
Disease progression or recurrence ≤ 12 months after autologous hematopoietic stem cell transplantation (HSCT)
For subjects who are considered transplant-ineligible: progressive disease as best response after ≥ 4 cycles of first-line therapy and stable disease as best response after ≥ 2 cycles of second-line (salvage) therapy; subject must have received an anti-CD20 monoclonal antibody and an anthracycline as one of their qualifying regimens
All subjects must have received an appropriate chemoimmunotherapy regimen which at a minim

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Dallas?

Yes, this clinical trial (NCT06343311) has an active research site in Dallas, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Non-Hodgkin's Lymphoma Treatment Options in Dallas, TX

If you're searching for non-hodgkin's lymphoma treatment options in Dallas, TX, this clinical trial (NCT06343311) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-hodgkin's lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all non-hodgkin's lymphoma clinical trials near you to find additional studies recruiting in your area.

More Lymphoma Trials in Dallas, TX

See all lymphoma clinical trials recruiting in Dallas — not just this study.

Browse Lymphoma Trials in Dallas →

Browse More Trials by Condition

Lymphoma TrialsPulmonary Hypertension TrialsAll Conditions →

Ready to Join in Dallas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Dallas, TX